Kevin Lewis Otipoby

This inventor holds 15 USPTO granted patents and 21 published patent applications and 2 EPO patents. Top assignees: Pandion Operations, Inc., Seismic Therapeutic, Inc., Pandion Therapeutics, Inc.. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kevin Lewis Otipoby. Retrieved from https://idiyas.com/inventor/kevin-lewis-otipoby

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 (Patent Applications = 21)

% Patents Active = 100.0

EPO Patents = 2 (Patent Applications = 14)

Average Co-Inventor Count = 5.9

ph-index = 3

Forward Citations = 56(Granted Patents)

Location History:

Cambridge, MA (US) (2019 - 2021)
Ashland, MA (US) (2019 - 2024)
Watertown, MA (US) (2024)

Company Filing History:

8 out of 10

Pandion Operations, Inc.

patents

3 out of 4

Seismic Therapeutic, Inc.

patents

2 out of 3

Pandion Therapeutics, Inc.

Pandion Operation, Inc.

patent

Years Active: 2019-2026

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12760103 - VARIANT IgG FC POLYPEPTIDES AND USES THEREOF (2026-10-13),

2. RE50550 - IL-2 muteins and uses thereof (2025-08-26),

3. 12129499 - Protease variants and uses thereof (2024-10-29),

4. 12030945 - Variant IgG Fc polypeptides and uses thereof (2024-07-09),

5. 11981715 - Tissue targeted immunotolerance with a CD39 effector (2024-05-14),

6. 11965008 - IL-2 muteins and uses thereof (2024-04-23),

7. 11945852 - IL-2 muteins and uses thereof (2024-04-02),

8. 11779632 - IL-2 muteins and uses thereof (2023-10-10),

9. 11739146 - MAdCAM targeted immunotolerance (2023-08-29),

10. 11091527 - IL-2 muteins and uses thereof (2021-08-17),

11. 11091526 - IL-2 muteins and uses thereof (2021-08-17),

12. 10946068 - IL-2 muteins and uses thereof (2021-03-16),

13. 10280169 - Biaryl bruton's tyrosine kinase inhibitors (2019-05-07),

14. 10174092 - IL-2 muteins (2019-01-08),

15. 10174091 - IL-2 muteins (2019-01-08),

Title: Kevin Lewis Otipoby: Pioneering Inventor from Cambridge

Introduction: Kevin Lewis Otipoby is a distinguished inventor based in Cambridge, MA, known for his groundbreaking contributions to various fields of technology and innovation.

Latest Patents: Kevin Lewis Otipoby holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his versatility and ingenuity in inventing cutting-edge solutions.

Career Highlights: With a career spanning over two decades, Kevin Lewis Otipoby has worked with renowned research institutions and leading tech companies, consistently pushing the boundaries of what is possible through his inventive spirit.

Collaborations: Throughout his career, Kevin Lewis Otipoby has collaborated with top scientists, engineers, and inventors, fostering a culture of innovation and excellence in all his projects.

Conclusion: Kevin Lewis Otipoby's passion for innovation and his relentless pursuit of technological advancement make him a true pioneer in the world of inventions, inspiring the next generation of inventors to dream big and create the future.

Profile summary based on public USPTO records.